Conversion of atrial fibrillation with ajmaline in a pregnant woman with Wolff-Parkinson-White syndrome.
Pregnancy is related to an increased frequency of arrhythmias in asymptomatic patients with Wolff-Parkinson-White syndrome, which might lead to sudden death. A 40-year-old woman, with Wolff-Parkinson-White syndrome which was not diagnosed until pregnancy, presented in the 34th week with an atrial fibrillation, with high risk criteria for ventricular fibrillation. Intravenous ajmaline was given to convert the tachyarrhythmia to sinus rhythm. We obtained an excellent maternal control with no maternal or fetal adverse effects.
Mozo de Rosales
F
F
Department of Obstetrics and Gynecology, University of Basque Country, Hospital de Cruces, Baracaldo, Vizcaya, Spain.
Moreno
J
J
Bodegas
A
A
Melchor
J C
JC
Fernández LLebrez
L
L
Aranguren
G
G
D000328:Adult; D000404:Ajmaline / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D004562:Electrocardiography; D005260:Female; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy* / Q000503:physiopathology
D000404:Ajmaline